US Stock MarketDetailed Quotes

NIU Niu Technologies

Watchlist

2.050
-0.030-1.44%

Close Apr 25 16:00 ET

2.000
-0.050-2.44%

Post 16:10 ET

159.08MMarket Cap-4288P/E (TTM)

Niu Technologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

(FY)Dec 31, 2016

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

176.92%93.74M

-136.46%-121.86M

-28.23%334.17M

160.58%465.6M

1,985.17%178.68M

-89.30%8.57M

165.06%80.06M

-123.05M

Net income from continuing operations

-449.58%-271.84M

-121.90%-49.46M

33.90%225.82M

-11.28%168.65M

154.46%190.08M

-89.01%-349.03M

20.65%-184.66M

---232.72M

Operating gains losses

66.78%-5.96M

5.78%-17.95M

-33.01%-19.05M

-112.22%-14.32M

-58.21%-6.75M

-104.00%-4.27M

-151.30%-2.09M

--4.08M

Depreciation and amortization

3.75%148.06M

49.48%142.71M

90.04%95.47M

54.92%50.24M

71.75%32.43M

93.72%18.88M

87.88%9.75M

--5.19M

Deferred tax

-80.15%-10.95M

-240.68%-6.08M

123.81%4.32M

-2,507.85%-18.15M

--753.81K

--0

----

Other non cash items

-2.61%8.3M

-20.55%8.53M

--10.73M

----

-19.78%34.5M

--43.01M

----

Change In working capital

105.94%17.33M

-727.00%-291.86M

-115.13%-35.29M

428.47%233.26M

-377.75%-71.01M

-82.91%25.57M

578.56%149.63M

--22.05M

-Change in receivables

213.26%78.71M

58.76%-69.5M

-1,357.36%-168.52M

120.99%13.4M

-49.12%-63.86M

-615.55%-42.83M

143.23%8.31M

---19.22M

-Change in inventory

101.68%2.63M

-19.00%-156.11M

-529.19%-131.19M

165.40%30.57M

35.45%-46.74M

-237.67%-72.41M

42.54%-21.44M

---37.32M

-Change in prepaid assets

95.98%-5.06M

-408.36%-125.89M

-2,391.40%-24.76M

127.40%1.08M

79.85%-3.94M

-179.88%-19.57M

323.65%24.5M

---10.95M

-Change in payables and accrued expense

-185.81%-55.77M

-78.69%64.99M

93.01%305.03M

315.09%158.04M

-78.89%38.07M

95.48%180.37M

22.18%92.27M

--75.52M

-Change in other current assets

441.81%6.27M

-220.67%-1.83M

488.03%1.52M

83.81%-391.74K

-1,758.23%-2.42M

---130.2K

--0

-Change in other current liabilities

41.24%-9.75M

-30.32%-16.59M

-317.67%-12.73M

998.03%5.85M

-89.82%532.46K

-7.94%5.23M

--5.68M

----

-Change in other working capital

-97.73%296.22K

381.22%13.06M

-118.80%-4.65M

236.29%24.71M

129.28%7.35M

-162.25%-25.09M

187.52%40.31M

--14.02M

Cash from discontinued investing activities

Operating cash flow

176.92%93.74M

-136.46%-121.86M

-28.23%334.17M

160.58%465.6M

1,985.17%178.68M

-89.30%8.57M

165.06%80.06M

---123.05M

Investing cash flow

Cash flow from continuing investing activities

-45.64%216.31M

234.85%397.89M

44.87%-295.06M

-14.39%-535.23M

-351.68%-467.89M

-85.22%-103.59M

6.71%-55.93M

-59.95M

Net PPE purchase and sale

41.68%-78.93M

52.63%-135.35M

-155.71%-285.75M

2.18%-111.75M

-256.78%-114.23M

-37.74%-32.02M

-125.24%-23.24M

---10.32M

Net intangibles purchase and sale

----

-48.75%-39.84M

-25.90%-26.78M

---21.27M

--0

Net investment purchase and sale

-44.63%295.25M

6,229.44%533.24M

97.73%-8.7M

-17.37%-383.65M

-549.85%-326.88M

-53.90%-50.3M

34.14%-32.68M

---49.63M

Net other investing changes

----

---614.07K

----

Cash from discontinued investing activities

Investing cash flow

-45.64%216.31M

234.85%397.89M

44.87%-295.06M

-14.39%-535.23M

-351.68%-467.89M

-85.22%-103.59M

6.71%-55.93M

---59.95M

Financing cash flow

Cash flow from continuing financing activities

-233.46%-59.35M

-384.92%-17.8M

147.45%6.25M

-137.31%-13.16M

-93.65%35.28M

708.38%555.38M

-69.47%68.7M

225.01M

Net issuance payments of debt

-200.00%-60M

---20M

--0

-199.94%-37.39M

218.60%37.42M

-82.91%11.74M

-61.57%68.7M

--178.77M

Net common stock issuance

----

--402.34M

--0

--3.36K

Net preferred stock issuance

----

--161.39M

--0

--110.95M

Proceeds from stock option exercised by employees

-70.31%654.02K

-64.73%2.2M

-74.22%6.25M

2,330.52%24.23M

--996.93K

--0

----

Net other financing activities

----

84.42%-3.13M

---20.09M

----

---64.71M

Cash from discontinued financing activities

Financing cash flow

-233.46%-59.35M

-384.92%-17.8M

147.45%6.25M

-137.31%-13.16M

-93.65%35.28M

708.38%555.38M

-69.47%68.7M

--225.01M

Net cash flow

Beginning cash position

66.68%720.63M

9.32%432.34M

-21.16%395.47M

-32.97%501.6M

165.47%748.32M

39.47%281.89M

329.56%202.11M

--47.05M

Current changes in cash

-2.92%250.7M

469.28%258.24M

154.79%45.36M

67.39%-82.8M

-155.16%-253.93M

395.88%460.36M

121.00%92.84M

--42.01M

Effect of exchange rate changes

-70.33%8.91M

453.85%30.04M

63.61%-8.49M

-423.78%-23.33M

18.62%7.21M

146.50%6.07M

-733.66%-13.06M

--2.06M

End cash Position

36.03%980.24M

66.68%720.63M

9.32%432.34M

-21.16%395.47M

-32.97%501.6M

165.47%748.32M

209.35%281.89M

--91.12M

Free cash flow

105.75%14.8M

-631.09%-257.21M

-84.58%48.43M

733.68%314.02M

184.23%37.67M

-178.71%-44.72M

142.60%56.82M

---133.37M

Currency Unit

CNY

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017	(FY)Dec 31, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	176.92%93.74M	-136.46%-121.86M	-28.23%334.17M	160.58%465.6M	1,985.17%178.68M	-89.30%8.57M	165.06%80.06M	-123.05M
Net income from continuing operations	-449.58%-271.84M	-121.90%-49.46M	33.90%225.82M	-11.28%168.65M	154.46%190.08M	-89.01%-349.03M	20.65%-184.66M	---232.72M
Operating gains losses	66.78%-5.96M	5.78%-17.95M	-33.01%-19.05M	-112.22%-14.32M	-58.21%-6.75M	-104.00%-4.27M	-151.30%-2.09M	--4.08M
Depreciation and amortization	3.75%148.06M	49.48%142.71M	90.04%95.47M	54.92%50.24M	71.75%32.43M	93.72%18.88M	87.88%9.75M	--5.19M
Deferred tax	-80.15%-10.95M	-240.68%-6.08M	123.81%4.32M	-2,507.85%-18.15M	--753.81K	--0	----	----
Other non cash items	-2.61%8.3M	-20.55%8.53M	--10.73M	----	----	-19.78%34.5M	--43.01M	----
Change In working capital	105.94%17.33M	-727.00%-291.86M	-115.13%-35.29M	428.47%233.26M	-377.75%-71.01M	-82.91%25.57M	578.56%149.63M	--22.05M
-Change in receivables	213.26%78.71M	58.76%-69.5M	-1,357.36%-168.52M	120.99%13.4M	-49.12%-63.86M	-615.55%-42.83M	143.23%8.31M	---19.22M
-Change in inventory	101.68%2.63M	-19.00%-156.11M	-529.19%-131.19M	165.40%30.57M	35.45%-46.74M	-237.67%-72.41M	42.54%-21.44M	---37.32M
-Change in prepaid assets	95.98%-5.06M	-408.36%-125.89M	-2,391.40%-24.76M	127.40%1.08M	79.85%-3.94M	-179.88%-19.57M	323.65%24.5M	---10.95M
-Change in payables and accrued expense	-185.81%-55.77M	-78.69%64.99M	93.01%305.03M	315.09%158.04M	-78.89%38.07M	95.48%180.37M	22.18%92.27M	--75.52M
-Change in other current assets	441.81%6.27M	-220.67%-1.83M	488.03%1.52M	83.81%-391.74K	-1,758.23%-2.42M	---130.2K	--0	--0
-Change in other current liabilities	41.24%-9.75M	-30.32%-16.59M	-317.67%-12.73M	998.03%5.85M	-89.82%532.46K	-7.94%5.23M	--5.68M	----
-Change in other working capital	-97.73%296.22K	381.22%13.06M	-118.80%-4.65M	236.29%24.71M	129.28%7.35M	-162.25%-25.09M	187.52%40.31M	--14.02M
Cash from discontinued investing activities
Operating cash flow	176.92%93.74M	-136.46%-121.86M	-28.23%334.17M	160.58%465.6M	1,985.17%178.68M	-89.30%8.57M	165.06%80.06M	---123.05M
Investing cash flow
Cash flow from continuing investing activities	-45.64%216.31M	234.85%397.89M	44.87%-295.06M	-14.39%-535.23M	-351.68%-467.89M	-85.22%-103.59M	6.71%-55.93M	-59.95M
Net PPE purchase and sale	41.68%-78.93M	52.63%-135.35M	-155.71%-285.75M	2.18%-111.75M	-256.78%-114.23M	-37.74%-32.02M	-125.24%-23.24M	---10.32M
Net intangibles purchase and sale	----	----	----	-48.75%-39.84M	-25.90%-26.78M	---21.27M	--0	--0
Net investment purchase and sale	-44.63%295.25M	6,229.44%533.24M	97.73%-8.7M	-17.37%-383.65M	-549.85%-326.88M	-53.90%-50.3M	34.14%-32.68M	---49.63M
Net other investing changes	----	----	---614.07K	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-45.64%216.31M	234.85%397.89M	44.87%-295.06M	-14.39%-535.23M	-351.68%-467.89M	-85.22%-103.59M	6.71%-55.93M	---59.95M
Financing cash flow
Cash flow from continuing financing activities	-233.46%-59.35M	-384.92%-17.8M	147.45%6.25M	-137.31%-13.16M	-93.65%35.28M	708.38%555.38M	-69.47%68.7M	225.01M
Net issuance payments of debt	-200.00%-60M	---20M	--0	-199.94%-37.39M	218.60%37.42M	-82.91%11.74M	-61.57%68.7M	--178.77M
Net common stock issuance	----	----	----	----	----	--402.34M	--0	--3.36K
Net preferred stock issuance	----	----	----	----	----	--161.39M	--0	--110.95M
Proceeds from stock option exercised by employees	-70.31%654.02K	-64.73%2.2M	-74.22%6.25M	2,330.52%24.23M	--996.93K	--0	--0	----
Net other financing activities	----	----	----	----	84.42%-3.13M	---20.09M	----	---64.71M
Cash from discontinued financing activities
Financing cash flow	-233.46%-59.35M	-384.92%-17.8M	147.45%6.25M	-137.31%-13.16M	-93.65%35.28M	708.38%555.38M	-69.47%68.7M	--225.01M
Net cash flow
Beginning cash position	66.68%720.63M	9.32%432.34M	-21.16%395.47M	-32.97%501.6M	165.47%748.32M	39.47%281.89M	329.56%202.11M	--47.05M
Current changes in cash	-2.92%250.7M	469.28%258.24M	154.79%45.36M	67.39%-82.8M	-155.16%-253.93M	395.88%460.36M	121.00%92.84M	--42.01M
Effect of exchange rate changes	-70.33%8.91M	453.85%30.04M	63.61%-8.49M	-423.78%-23.33M	18.62%7.21M	146.50%6.07M	-733.66%-13.06M	--2.06M
End cash Position	36.03%980.24M	66.68%720.63M	9.32%432.34M	-21.16%395.47M	-32.97%501.6M	165.47%748.32M	209.35%281.89M	--91.12M
Free cash flow	105.75%14.8M	-631.09%-257.21M	-84.58%48.43M	733.68%314.02M	184.23%37.67M	-178.71%-44.72M	142.60%56.82M	---133.37M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	Unqualified Opinion	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall